0000000000450335

AUTHOR

Torregrossa M V

showing 3 related works from this author

Dispersal of methicillin resistant Staphylococcus aureus (MRSA) in a burn intensive care unit.

2003

Methicillin resistant Staphylococcus aureus (MRSA) is a pathogen of special concern in intensive care units (ICUs). The burn units are a very susceptible habitat to colonization and infection events by this organism. In this paper isolation of MRSA from a sepsis case and from samples of the care unit air is described, along with simultaneous circulation of two clones of MRSA. Some peculiar epidemiological features of MRSA in burn intensive care wards are confirmed.

Cross InfectionIntensive Care UnitsStaphylococcus aureusBurn UnitsHumansMethicillin Resistancemethicillin resistant staphylococcus aureusStaphylococcal InfectionsSettore MED/42 - Igiene Generale E ApplicataBurnsAnnali di igiene : medicina preventiva e di comunita
researchProduct

Definition of criteria and indicators for the prevention of Healthcare-Associated Infections (HAIs) in hospitals for the purposes of Italian institut…

2017

Background. Healthcare-associated infections (HAIs) are an important issue in terms of quality of care. HAIs impact patient safety by contributing to higher rates of preventable mortality and prolonged hospita- lizations. In Italy, analysis of the currently available accreditation systems shows a substantial heteroge- neity of approaches for the prevention and surveillance of HAIs in hospitals. The aim of the present study is to develop and propose the use of a synthetic assessment tool that could be implemented homogenously throughout the nation. Methods. An analysis of nine international and of the 21 Italian regional accreditation systems was conducted in order to identify requirements a…

Process Assessment (Health Care)Cross InfectionProcess Assessment Health CareEnvironmental and Occupational HealthOutcome indicatorsProcess AssessmentHealthcare-Associated Infections (HAIs); Institutional accreditation; Outcome indicators; Patient safety; Performance monitoring; Public Health Environmental and Occupational Health; Infectious DiseasesSettore MED/42 - Igiene Generale E ApplicataHospitalsAccreditationHealthcare-Associated Infections (HAIs); Institutional accreditation; Outcome indicators; Patient safety; Performance monitoring; Cross Infection; Hospitals; Humans; Italy; Accreditation; Process Assessment (Health Care)Health CareHealthcare-Associated Infections (HAIs); Institutional accreditation; Outcome indicators; Patient safety; Performance monitoringInstitutional accreditationPatient safetyHealthcare-Associated Infections (HAIs); Institutional accreditation; Outcome indicators; Patient safety; Performance monitoring; Cross Infection; Hospitals; Humans; Italy; Accreditation; Process Assessment Health CareInfectious DiseasesHealthcare-Associated Infections (HAIs) Patient safety Institutional accreditation Performance monitoring Outcome indicatorsItalySettore MED/33 - Malattie Apparato LocomotoreHumansOutcome indicatorPublic HealthPerformance monitoringHealthcare-Associated Infections (HAIs)
researchProduct

Isolation of HTLV III/LAV from drug addicts in Palermo.

1987

The new human retroviruses HTLV III/LAV, implicated as the causative agent of AIDS, have been isolated from peripheral blood lymphocytes of 5 of 13 drugs abusers with acquired immunodeficiency syndrome-related complex (ARC). In one patient the virus was also found in cell-free plasma. No HTLV III/LAV was detected in or isolated from 5 clinically healthy drug abusers. The lymphocytes were cultured with interleukin 2 and expressed either a transcriptase reverse activity or HTLV III/LAV antigens within 2-3 weeks of cultivation. The viruses were also transmitted into normal lymphocytes from cord blood of human newborns. At the present state of development, virological investigation, other than …

HTLIII/LAV PalermoAIDS-Related Complex/microbiologyMaleRiskAIDS-Related ComplexSubstance-Related DisordersHIVHumansFemaleLymphocytesisolation HTLIII/LAVSettore MED/42 - Igiene Generale E ApplicataSicilyMicrobiologica
researchProduct